IMMUNO-ONCOLOGY INSIGHTS

Leveraging cutting edge tools to convert I-O data into knowledge

Guest Editor:
Jacques Moisan, Translational Innovation Platform - Immuno-Oncology Scientific Site Head (USA) at EMD Serono, Inc
Jacques Moisan
Translational Innovation Platform - Immuno-Oncology Scientific Site Head (USA) at EMD Serono, Inc
  • Advancing engineered cell and gene therapy with precision gene editing

    D Maddalo,
    J Lambourne,
    Danilo Maddalo
    Danilo Maddalo
    Group Leader, Translational Oncology, Genentech
    Dr. John Lambourne
    Dr. John Lambourne
    Research and Development Manager Horizon Discovery
    11 November 2021
    Watch now
  • Enabling clinical grade manufacturing of gene-engineered NK cells

    N Moker,
    E Ullrich,
    R Romee et al.
    Nina Möker
    Nina Möker
    R&D Reagents Manager, Allogeneic Cell Therapy, Miltenyi Biotec
    Prof. Dr. Evelyn Ullrich
    Prof. Dr. Evelyn Ullrich
    Arbeitsgruppe Zelluläre Immunologie, Universitätsklinikum, Frankfurt am Main (kgu.de)
    Rizwan Romee, MD
    Rizwan Romee, MD
    Associate Professor of Medicine, Harvard Medical School, Dana Farber Cancer Institute
    Volker Huppert
    Volker Huppert
    Chief Development Officer Glycostem Therapeutics
    30 November 2021
    Watch now
  • Gain deeper insights into the mechanisms of immune cell killing of tumor cells:...

    C Souders,
    T Dale,
    N Bevan et al.
    Dr Colby Souders
    Dr Colby Souders
    Chief Scientific Officer, Abveris
    Tim Dale, PhD
    Tim Dale, PhD
    Head of BioAnalytics Applications, Sartorius
    Nicola Bevan
    Nicola Bevan
    Manager of Cell Imaging Applications, Sartorius
     Jeffrey Skolnik, M.D.
    Jeffrey Skolnik, M.D.
    Senior Vice President, Clinical Development, Inovio
    6 October 2021
    Watch now
  • The therapeutic gene editing solution – cell therapy for solid tumors

    B Sasu,
    P Sivakumar,
    J Trager et al.
    Barbra Sasu, PhD
    Barbra Sasu, PhD
    Chief Scientific Officer, Allogene Therapeutics
    Pallavur Sivakumar, PhD
    Pallavur Sivakumar, PhD
    Scientific Vice President and Head of Discovery, Immuno-Oncology and Cell Therapy Thematic Research Center, Bristol Myers Squibb
    James Trager, PhD
    James Trager, PhD
    Chief Scientific Officer, Nkarta Therapeutics
    Jennifer Harbottle, PhD
    Jennifer Harbottle, PhD
    Senior Scientist, R&D, Cell and Gene Therapy, Horizon Discovery
    30 September 2021
    Watch now
  • Get your non-viral T cell engineering process ready for clinical manufacturing

    M Rietenbach,
    S Wild,
    K Patel
    Melanie Rietenbach
    Melanie Rietenbach
    Global Product Manager Miltenyi Biotec
    Stefan Wild
    Stefan Wild
    Senior Manager, Research and Development, Miltenyi Biotec
    Kunal Patel
    Kunal Patel
    Process Engineering Manager, Miltenyi Biotec
    21 September 2021
    Watch now
  • Cell-based therapies for cancer treatment: leveraging advanced flow cytometry...

    N Senutovitch,
    R Fan,
    T Laskowski
    Nina Senutovitch Ph.D.
    Nina Senutovitch Ph.D.
    Senior Scientist, Product Development, Cell Imaging, Sartorius
    Professor Rong Fan
    Professor Rong Fan
    Professor of Biomedical Engineering, Yale University
    Tamara J. Laskowski, Ph.D.
    Tamara J. Laskowski, Ph.D.
    Scientific Project Director, Adoptive Cell Therapy Platform, Dept. of Stem Cell Transplantation and Cellular Therapy MD Anderson Cancer Center
    5 August 2021
    Watch now
  • Latest content

    Advancing engineered cell and gene therapy with precision gene editing

    D Maddalo,
    J Lambourne,
    Danilo Maddalo
    Danilo Maddalo
    Group Leader, Translational Oncology, Genentech
    Dr. John Lambourne
    Dr. John Lambourne
    Research and Development Manager Horizon Discovery
    11 November 2021
    Watch now